EMEIS SA (ORP.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ORP - FR001400NLM4 - Common Stock
12.465 EUR
+0.15 (+1.24%)
Taking everything into account, ORP scores 4 out of 10 in our fundamental rating. ORP was compared to 30 industry peers in the Health Care Providers & Services industry. While ORP is still in line with the averages on profitability rating, there are concerns on its financial health. ORP is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
- In the past year ORP was profitable.
- In the past year ORP had a positive cash flow from operations.
- Of the past 5 years ORP 4 years were profitable.
- In the past 5 years ORP always reported a positive cash flow from operatings.
1.2 Ratios
- ORP has a better Return On Assets (9.74%) than 100.00% of its industry peers.
- ORP's Return On Equity of 71.82% is amongst the best of the industry. ORP outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.74% | ||
| ROE | 71.82% | ||
| ROIC | N/A |
ROA(3y)-5.89%
ROA(5y)-3.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ORP's Profit Margin of 26.07% is amongst the best of the industry. ORP outperforms 100.00% of its industry peers.
- In the last couple of years the Profit Margin of ORP has grown nicely.
- ORP does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 26.07% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y32.24%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- ORP does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ORP has less shares outstanding
- The debt/assets ratio for ORP has been reduced compared to a year ago.
2.2 Solvency
- ORP has an Altman-Z score of 0.39. This is a bad value and indicates that ORP is not financially healthy and even has some risk of bankruptcy.
- ORP has a Altman-Z score of 0.39. This is amonst the worse of the industry: ORP underperforms 85.71% of its industry peers.
- ORP has a Debt/Equity ratio of 4.30. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of ORP (4.30) is worse than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.3 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.39 |
ROIC/WACCN/A
WACC5.23%
2.3 Liquidity
- ORP has a Current Ratio of 0.60. This is a bad value and indicates that ORP is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.60, ORP is doing worse than 85.71% of the companies in the same industry.
- ORP has a Quick Ratio of 0.60. This is a bad value and indicates that ORP is not financially healthy enough and could expect problems in meeting its short term obligations.
- ORP has a Quick ratio of 0.60. This is in the lower half of the industry: ORP underperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 360.39% over the past year.
- ORP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 116.08% yearly.
- ORP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.04%.
- The Revenue has been growing by 8.73% on average over the past years. This is quite good.
EPS 1Y (TTM)360.39%
EPS 3Y301.6%
EPS 5Y116.08%
EPS Q2Q%278.1%
Revenue 1Y (TTM)11.04%
Revenue growth 3Y9.84%
Revenue growth 5Y8.73%
Sales Q2Q%11.4%
3.2 Future
- Based on estimates for the next years, ORP will show a very strong growth in Earnings Per Share. The EPS will grow by 26.14% on average per year.
- ORP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.11% yearly.
EPS Next Y99.7%
EPS Next 2Y41.51%
EPS Next 3Y26.14%
EPS Next 5YN/A
Revenue Next Year6.41%
Revenue Next 2Y9.12%
Revenue Next 3Y8.11%
Revenue Next 5YN/A
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 1.20, the valuation of ORP can be described as very cheap.
- Compared to the rest of the industry, the Price/Earnings ratio of ORP indicates a rather cheap valuation: ORP is cheaper than 100.00% of the companies listed in the same industry.
- ORP is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- ORP is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.2 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ORP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as ORP's earnings are expected to grow with 26.14% in the coming years.
PEG (NY)0.01
PEG (5Y)0.01
EPS Next 2Y41.51%
EPS Next 3Y26.14%
5. Dividend
5.1 Amount
- No dividends for ORP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ORP (7/2/2024, 5:28:19 PM)
12.465
+0.15 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-14 2024-05-14
Earnings (Next)07-24 2024-07-24
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.98B
Revenue(TTM)5.20B
Net Income(TTM)1.35B
Analysts48.89
Price Target170.74 (1269.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-24.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)98.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.2 | ||
| Fwd PE | N/A | ||
| P/S | 0.38 | ||
| P/FCF | N/A | ||
| P/OCF | 5.42 | ||
| P/B | 1.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)10.36
EY83.11%
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)2.3
OCFY18.45%
SpS32.65
BVpS11.85
TBVpS-6.36
PEG (NY)0.01
PEG (5Y)0.01
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.74% | ||
| ROE | 71.82% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 26.07% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-5.89%
ROA(5y)-3.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y85.55%
PM growth 5Y32.24%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.3 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.39 |
F-Score6
WACC5.23%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.91%
Cap/Sales(5y)16.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)360.39%
EPS 3Y301.6%
EPS 5Y116.08%
EPS Q2Q%278.1%
EPS Next Y99.7%
EPS Next 2Y41.51%
EPS Next 3Y26.14%
EPS Next 5YN/A
Revenue 1Y (TTM)11.04%
Revenue growth 3Y9.84%
Revenue growth 5Y8.73%
Sales Q2Q%11.4%
Revenue Next Year6.41%
Revenue Next 2Y9.12%
Revenue Next 3Y8.11%
Revenue Next 5YN/A
EBIT growth 1Y81.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.08%
EBIT Next 3Y32.13%
EBIT Next 5YN/A
FCF growth 1Y-135.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.64%
OCF growth 3Y-22.21%
OCF growth 5Y-2.48%
EMEIS SA / ORP.PA FAQ
Can you provide the ChartMill fundamental rating for EMEIS SA?
ChartMill assigns a fundamental rating of 4 / 10 to ORP.PA.
What is the valuation status of EMEIS SA (ORP.PA) stock?
ChartMill assigns a valuation rating of 4 / 10 to EMEIS SA (ORP.PA). This can be considered as Fairly Valued.
How profitable is EMEIS SA (ORP.PA) stock?
EMEIS SA (ORP.PA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of EMEIS SA (ORP.PA) stock?
The Price/Earnings (PE) ratio for EMEIS SA (ORP.PA) is 1.2 and the Price/Book (PB) ratio is 1.05.
How financially healthy is EMEIS SA?
The financial health rating of EMEIS SA (ORP.PA) is 1 / 10.